|
1) Kanai T, Nemoto Y, Tomita T, et al. Persistent retention of colitogenic CD4＋ memory T cells causes inflammatory bowel diseases to become intractable. Inflamm Bowel Dis (in press)
|
|
|
|
|
2) Sprent J, Surh CD. T cell memory. Annu Rev Immunol. 2002; 20: 551-79
|
|
|
|
|
3) Powrie F, Leach MW, Mauze S, et al. Phenotypically distinct subsets of CD4＋ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993; 5: 1461-71
|
|
|
|
|
|
4) Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003; 3: 269-79
|
|
|
|
|
|
5) Fry TJ, Mackall CL. The many faces of IL-7: From lymphopoiesis to peripheral T cell maintenance. J Immunol. 2005; 174: 6571-6
|
|
|
|
|
|
6) Totsuka T, Kanai T, Nemoto Y, et al. IL-7 is essential for the development and the persistence of chronic colitis. J Immunol. 2007; 178: 4737-48
|
|
|
|
|
|
7) Tomita T, Kanai T, Nemoto Y, et al. Systemic, but not intestinal, IL-7 is essential for the persistence of chronic colitis. J Immunol. 2008; 180: 383-90
|
|
|
|
|
|
8) Tomita T, Kanai T, Fujii T, et al. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4＋ T cells in chronic colitis. J Immunol. 2008; 180: 5291-9
|
|
|
|
|
|
9) Tomita T, Kanai T, Nemoto Y, et al. Colitogenic CD4＋ effector-memory T cells actively recirculate in chronic colitic mice. Inflamm Bowel Dis (in press)
|
|
|
|
|
|
10) Fujii R, Kanai T, Nemoto Y, et al. FTY720 suppresses CD4＋CD44highCD62L− effector memory T cell-mediated colitis. Am J Physiol Gastrointest Liver Physiol. 2006; 291: G267-74
|
|
|
|
|
|
11) Makita S, Kanai T, Nemoto Y, et al. Intestinal lamina propria retaining CD4＋CD25＋ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol. 2007; 178: 4937-46
|
|
|
|
|
|
12) Di Rosa F, Pabst R. The bone marrow: a nest for migratory memory T cells. Trends Immunol. 2005; 26: 360-6
|
|
|
|
|
|
13) Nemoto Y, Kanai T, Makita S, et al. Bone marrow retaining colitogenic CD4＋ T cells may be a pathogenic reservoir for chronic colitis. Gastroenterology. 2007; 132: 176-89
|
|
|
|
|
|
14) Namen AE, Lupton S, Hjerrild K, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature. 1988; 333: 571-3
|
|
|
|
|
|
15) Watanabe M, Watanabe N, Iwao Y, et al. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. J Clin Immunol. 1997; 17: 282-92
|
|
|
|
|
|
16) Kanai T, Hibi T, Watanabe M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther. 2006; 6: 453-66
|
|
|
|
|
|
17) Kanai T, Makita S, Kawamura T, et al. Extracorporeal elimination of TNF-alpha-producing CD14dullCD16＋ monocytes in leukocytapheresis therapy for ulcerative colitis. Inflamm Bowel Dis. 2007; 13: 284-90
|
|
|
|
|
|
18) Blanco Y, Saiz A, Carreras E, et al. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol. 2005; 4: 54-63
|
|
|
|
|
|
19) Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology. 2005; 128: 552-63
|
|
|
|
|